We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
-20.18%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.95B
AUM Growth
-$1.51B
(-44%)
Cap. Flow
-$541M
Cap. Flow
% of AUM
-27.79%
Top 10 Holdings %
Top 10 Hldgs %
66.18%
Holding
59
New
2
Increased
9
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IVA
Inventiva
IVA
|
+$38.9M |
| 2 |
Senti Biosciences Holdings
SNTI
|
+$35.6M |
| 3 |
Trevi Therapeutics
TRVI
|
+$27.9M |
| 4 |
Palo Alto Networks
PANW
|
+$17.4M |
| 5 |
Nkarta
NKTX
|
+$8.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$644M |
| 2 |
IonQ
IONQ
|
+$20.7M |
| 3 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
+$13M |
| 4 |
Enliven Therapeutics
ELVN
|
+$2.81M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
+$818K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.32% |
| 2 | Technology | 12.48% |
| 3 | Consumer Staples | 11.56% |
| 4 | Industrials | 4.58% |
| 5 | Communication Services | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEUE
1
DELISTED
NeueHealth
NEUE
| $397M | 20.4% |
2,727,652
| – | – |
|
2
Coursera
COUR
$1.71B
| $225M | 11.56% |
15,867,769
| – | – |
|
|
3
IonQ
IONQ
$12.3B
| $115M | 5.93% |
26,350,067
-2,927,785
| -10% | -$20.7M |
|
|
ACLX
4
DELISTED
Arcellx
ACLX
| $113M | 5.79% |
6,750,264
+312,500
| +5% | +$4.03M |
|
5
CRISPR Therapeutics
CRSP
$4.64B
| $96.6M | 4.96% |
1,590,002
| – | – |
|
6
Cloudflare
NET
$94.5B
| $82.1M | 4.22% |
1,877,510
| – | – |
|
7
Mirum Pharmaceuticals
MIRM
$6.72B
| $81.5M | 4.19% |
4,187,801
| – | – |
|
8
Monte Rosa Therapeutics
GLUE
$1.85B
| $74.5M | 3.83% |
7,703,205
| – | – |
|
|
BGRY
9
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $55.4M | 2.85% |
38,226,621
| – | – |
|
|
CTIC
10
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $48M | 2.47% |
8,047,228
+906,778
| +13% | +$4.64M |
|
|
11
Nkarta
NKTX
$157M
| $44M | 2.26% |
3,571,640
+666,666
| +23% | +$8.75M |
|
12
Aurinia Pharmaceuticals
AUPH
$1.92B
| $39.9M | 2.05% |
3,969,834
| – | – |
|
13
Savara
SVRA
$1.08B
| $36.7M | 1.88% |
24,137,931
| – | – |
|
|
14
Trevi Therapeutics
TRVI
$2.6B
| $32M | 1.64% |
11,373,174
+11,370,376
| +406,375% | +$27.9M |
|
|
DM
15
DELISTED
Desktop Metal, Inc.
DM
| $31.7M | 1.63% |
1,440,759
| – | – |
|
|
IVA
16
Inventiva
IVA
$1.07B
| $31.6M | 1.62% |
5,572,953
+4,274,253
| +329% | +$38.9M |
|
|
ADAP
17
DELISTED
Adaptimmune Therapeutics
ADAP
| $29M | 1.49% |
17,082,612
+1
| +0% | +$2 |
|
|
AVEO
18
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $25.9M | 1.33% |
3,952,957
| – | – |
|
|
OYST
19
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $25.7M | 1.32% |
5,925,287
| – | – |
|
20
Geron
GERN
$905M
| $25.3M | 1.3% |
16,318,681
| – | – |
|
21
BuzzFeed
BZFD
$99.9M
| $23.6M | 1.21% |
3,833,473
| – | – |
|
|
UTRS
22
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $23.5M | 1.21% |
500,097
| – | – |
|
|
VRNA
23
DELISTED
Verona Pharma
VRNA
| $21.4M | 1.1% |
5,108,563
| – | – |
|
24
Rhythm Pharmaceuticals
RYTM
$7.38B
| $20.4M | 1.05% |
4,912,306
| – | – |
|
|
AKUS
25
DELISTED
Akouos Inc
AKUS
| $20.2M | 1.04% |
4,298,488
| – | – |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q2 2022 Portfolio in Review
As of Q2 2022, NEA Management Company held 59 positions worth $1.95B, down 44% from $3.46B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
NEA Management Company withdrew a net $541M in Q2 2022, closing 2 positions and reducing 3 holdings. Its most notable exit was Robinhood, an estimated $644M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, NEA Management Company opened a new position in Senti Biosciences Holdings worth $7.46M.
- NEA Management Company's largest Q2 2022 buy was Senti Biosciences Holdings: 442,973 shares worth $7.46M.
- NEA Management Company added most to Inventiva in Q2 2022, an estimated $38.9M increase.
- NEA Management Company's biggest Q2 2022 reduction was IonQ, cutting an estimated $20.7M.
- NEA Management Company fully exited Robinhood in Q2 2022, selling an estimated $644M.
- NEA Management Company's ten largest holdings make up 66% of its $1.95B portfolio in Q2 2022.
- NEA Management Company opened 2 new positions and closed 2 in Q2 2022.
- NEA Management Company's portfolio value fell 44% quarter-over-quarter to $1.95B.
Based on NEA Management Company's 13F filing for Q2 2022, filed 15 Aug 2022.